PCM
SBBP

Prelude Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Prelude Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-57,126
Closed -$284K – 2293
2019
Q1 		$284K Hold
57,126
– – 0.02% 615
2018
Q4 		$256K Buy
57,126
+15,047
+36% +$73.5K 0.02% 649
2018
Q3 		$204K Hold
42,079
– – 0.01% 758
2018
Q2 		$252K Hold
42,079
– – 0.02% 704
2018
Q1 		$372K Buy
+42,079
New +$315K 0.03% 517

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Prelude Capital Management's SBBP Position: Q2 2019 in Review

Prelude Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2019, closing a stake of 57,126 shares — an estimated $284K sold.

Prelude Capital Management first reported a position in SBBP in Q1 2018 and held it in 5 quarters. The position peaked at $372K in Q1 2018. 58 funds tracked by Wall St. Rank hold SBBP as of Q2 2019.

  • Prelude Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q2 2019 after selling out during the quarter.
  • Prelude Capital Management sold 57,126 Strongbridge Biopharma plc. shares in Q2 2019, an estimated $284K.
  • Prelude Capital Management first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 5 quarters.
  • Prelude Capital Management's Strongbridge Biopharma plc. position peaked at $372K in Q1 2018.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.